Sentences with phrase «uncertain market demand»

The decision is also seen as the company's response to the uncertain market demand for its smartphone OLED panels.

Not exact matches

Neither company has achieved sustained profitability, and both are operating in markets where demand is uncertain.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Falih also said there remained many variables in the market as demand was uncertain and new supplies were emerging at a quicker pace than anticipated.

It should reduce demand, «but the impact of these policy measures on the market is uncertain,» it said.

«Pursuing creative but untested notions of demand as a demand resource in upcoming capacity market auctions and thus facing the prospect of several years of uncertain administrative and judicial litigation serves to undermine completely the very purpose of the capacity market — namely, to provide a certain stream of forward revenues to assist capital formation for resource investment.»

Increased energy demand in emerging markets, uncertain energy prices and international pressure to reduce carbon emissions, mean governments and businesses see the economic and security benefits of shifting to clean energy.

Demand will spike for trade, regulatory, and financial services attorneys to help clients navigate regulatory and legislative reform, but transactional work is expected to be hit hard, as investors tend to be reluctant to do deals when the market is so volatile and uncertain.

Corporate clients in the current buyers» market are increasingly demanding lower, fixed prices and value - based Alternative Fee Arrangements («AFAs») in lieu of hourly billing — making law firms bear the «risk of loss» in uncertain but complex litigation and transaction matters — even as the costs of running law firms continue to climb.

It's a sure bet that the market - rate seniors housing pipeline will catch up to the retiring baby boom demand during the next two decades — supply usually follows abundant money — but what's more uncertain is how the sector will fill the expected boom...